{"date":"2026-06-22","count":25,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6431-2026-06-22-1905-15wbhi8","company_id":"6431","company":"光麗-KY","market":"上市","industry":"生技醫療","date":"2026-06-22","time":"19:05:03","subject":"代子公司宸曜醫務管理顧問股份有限公司公告取得嘉蒂保醫藥股份有限公司百分之百股權","clause":"第11款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：光麗-KY（6431），2026-06-22 19:05，「代子公司宸曜醫務管理顧問股份有限公司公告取得嘉蒂保醫藥股份有限公司百分之百股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-06-22-1829-k1qdeo","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-06-22","time":"18:29:08","subject":"公告本公司第二屆審計委員會委員名單","clause":"第6款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-06-22 18:29，「公告本公司第二屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-06-22-1828-1n0gidz","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-06-22","time":"18:28:34","subject":"本公司115年度股東常會通過解除新任董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-06-22 18:28，「本公司115年度股東常會通過解除新任董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-06-22-1827-1jb97vz","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-06-22","time":"18:27:48","subject":"公告本公司115年股東常會全面改選董事當選名單暨董事變動達三分之一以上","clause":"第6款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-06-22 18:27，「公告本公司115年股東常會全面改選董事當選名單暨董事變動達三分之一以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-06-22-1826-1jb8ii5","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-06-22","time":"18:26:33","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-06-22 18:26，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-06-22-1753-19pqibn","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"17:53:03","subject":"公告本公司毛囊間質幹細胞外泌體藥物原料EXH-101，取得美國FDA之第II類DMF登記核可","clause":"第44款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-06-22 17:53，「公告本公司毛囊間質幹細胞外泌體藥物原料EXH-101，取得美國FDA之第II類DMF登記核可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-06-22-1710-1yqp04k","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"17:10:38","subject":"本公司與Samsung Biologics Co., Ltd.簽訂 TMB-365商業產品藥物原料之產品專屬協議","clause":"第10款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-06-22 17:10，「本公司與Samsung Biologics Co., Ltd.簽訂 TMB-365商業產品藥物原料之產品專屬協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-06-22-1619-1xdjlf8","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"16:19:39","subject":"公告本公司分派114年度現金股利之基準日","clause":"第31款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-06-22 16:19，「公告本公司分派114年度現金股利之基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-06-22-1609-ahexl4","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"16:09:58","subject":"公告本公司股票初次上櫃前現金增資員工認購股款催繳事宜","clause":"第44款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-06-22 16:09，「公告本公司股票初次上櫃前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-06-22-1555-1fqkmsr","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"15:55:30","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-06-22 15:55，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-06-22-1534-1j6rknd","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"15:34:21","subject":"公告本公司115年現金增資認股基準日等相關事宜(補充公告每股發行價格暨代收股款及存儲價款機構)","clause":"第11款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-06-22 15:34，「公告本公司115年現金增資認股基準日等相關事宜(補充公告每股發行價格暨代收股款及存儲價款機構)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2026-06-22-1531-1j46v82","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"15:31:30","subject":"公告本公司現金股利除息基準日","clause":"第14款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2026-06-22 15:31，「公告本公司現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-06-22-1442-1udd9xf","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"14:42:11","subject":"公告本公司新任法人董事指派代表人","clause":"第6款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-06-22 14:42，「公告本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-06-22-1439-1irfdyf","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"14:39:20","subject":"公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-06-22 14:39，「公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-06-22-1437-1y3dlcm","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"14:37:04","subject":"公告本公司115年股東常會決議通過解除董事及其代表人競業禁止之限制","clause":"第22款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-06-22 14:37，「公告本公司115年股東常會決議通過解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-06-22-1435-1m5oni5","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"14:35:40","subject":"公告本公司第二屆審計委員會委員及召集人","clause":"第6款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-06-22 14:35，「公告本公司第二屆審計委員會委員及召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-06-22-1430-1r2d1uw","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"14:30:16","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-06-22 14:30，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-06-22-1427-1nfv7b","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"14:27:14","subject":"公告本公司115年第一次股東常會董事全面改選當選名單暨三分之一以上董事發生變動","clause":"第6款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-06-22 14:27，「公告本公司115年第一次股東常會董事全面改選當選名單暨三分之一以上董事發生變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-06-22-1418-eik570","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"14:18:59","subject":"公告本公司第五屆薪資報酬委員會任期屆滿","clause":"第6款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-06-22 14:18，「公告本公司第五屆薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-06-22-1418-1jb8ii5","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"14:18:41","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-06-22 14:18，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-06-22-1416-1l6schj","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"14:16:59","subject":"公告本公司115年股東常會全面改選董事(含)獨立董事當選名單暨董事變動達三分之一","clause":"第6款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-06-22 14:16，「公告本公司115年股東常會全面改選董事(含)獨立董事當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2026-06-22-1415-1jb8ii5","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2026-06-22","time":"14:15:31","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2026-06-22 14:15，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-06-22-1016-1fjchxc","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-06-22","time":"10:16:14","subject":"本公司受邀參加永豐金證券於115年06月25日舉辦之法人說明會","clause":"第12款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-06-22 10:16，「本公司受邀參加永豐金證券於115年06月25日舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-06-22-0813-r0l433","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-06-22","time":"08:13:44","subject":"本公司ADC新藥GNX1021正式取得台灣衛生福利部食品藥物管理署（TFDA）臨床試驗核准","clause":"第53款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-06-22 08:13，「本公司ADC新藥GNX1021正式取得台灣衛生福利部食品藥物管理署（TFDA）臨床試驗核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-06-22-0758-i1pjvr","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-06-22","time":"07:58:42","subject":"代重要子公司台灣泰福生技股份有限公司公告決議辦理減資彌補虧損暨債權人通知事宜","clause":"第11款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-06-22 07:58，「代重要子公司台灣泰福生技股份有限公司公告決議辦理減資彌補虧損暨債權人通知事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}